http://www.zibb.com/all/theme/cq/CombinatoRx+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 25 Nov 2009 19:08:21 GMTWed, 25 Nov 2009 19:08:21 GMT608831http://www.zibb.com/all/theme/cq/CombinatoRx+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.combinatorx.com/CombinatorRx - See Us. See the Future. Company Products Discovery Investors & News Careers Contact CombinatoRx Singapore Investor Events Video: Our Technology Our Pipeline 06/18/08 CombinatoRx to Present at the Third Annual Piper Jaffray Europe Conference 05/30/08 CombinatoRx to Present at thehttp://www.combinatorx.com/CombinatoRx Incorporatedhttp://www.bostonmillennia.net/OurPortfolio/Default.asp?CategoryID=&PortfolioCompanyID=64Boston Millennia Partners' portfolio reflects Millennia's commitment towards building enduring, large-scale businesses that have the potential to provide superior financial returns to our investors.http://www.bostonmillennia.net/OurPortfolio/Default.asp?CategoryID=&PortfolioCompanyID=64CombinatoRx Incorporatedhttp://www.evaluatepharma.com/CoInfo/CoInfo-CRXX.htmEvaluatePharma provides historic and forecast sales from 1986 to 2010 for worldwide and US Rx (prescription drugs) and OTC drugs. EvaluatePharma analysts continuously update company models from SEC filings, annual reports, investor/analyst presentations, company press releases, FDA and USPTO.http://www.evaluatepharma.com/CoInfo/CoInfo-CRXX.htmCombinatoRx Incorporatedhttp://www.investorguide.com/stock-news.cgi?ticker=CRXXTrack Any Stock Instantly Just enter up to ten of your stocks in the Stock Tracker box, click the ADD button beside any of Today's Hot Stocks, or click ADD beside any of the stocks you've Recently Viewed.http://www.investorguide.com/stock-news.cgi?ticker=CRXXCombinatoRx Incorporatedhttp://www.newratings.com/headlines/CombinatoRx-Inc-_US20010A1034.htmlCopyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.http://www.newratings.com/headlines/CombinatoRx-Inc-_US20010A1034.htmlCombinatoRx Incorporatedhttp://www.biospace.com/news_story.aspx?NewsEntityId=60081BioSpace.com Search the Site News Jobs Companies Events Employers Post Job | Search Resumes Visit BioSpace.com Medical Device and Diagnostics Channel HOME spacer CAREER NETWORK spacer NEWS spacer HOTBEDS spacer EVENT CENTER spacer CAREER FAIRS spacer COMPANY PROFILES spacer BIOPHARM INSIGHT spacerhttp://www.biospace.com/news_story.aspx?NewsEntityId=60081CombinatoRx Incorporatedhttp://www.eastoncapital.com/portfolio/lifesci/combinatorx.phpCombinatoRx, Incorporated CombinatoRx (NASD:CRXX) is a biopharmaceutical company pioneering a systems biology approach to create new combination medicines that attack diseases on multiple fronts.http://www.eastoncapital.com/portfolio/lifesci/combinatorx.phpCombinatoRx Incorporatedhttp://www.fiercebiotech.com/story/combinatorx-to-pocket-42m-in-new-collaboration/2005-10-04FierceBiotech is the biotech industry daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and fda approval news.http://www.fiercebiotech.com/story/combinatorx-to-pocket-42m-in-new-collaboration/2005-10-04CombinatoRx Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=273992006 MAY 10 - (NewsRx.com) -- CombinatoRx, Incorporated (CRXX) announced preliminary results of its randomized, blinded, placebo-controlled clinical trial of CRx-119 in patients with chronic adult periodontitis, an immuno-inflammatory disease model.http://www.pharmacychoice.com/News/article.cfm?Article_ID=27399CombinatoRx Incorporatedhttp://www.thelabrat.com/jobs/companies/CombinatoRx.shtmlCombinatoRx, Incorporated is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs.http://www.thelabrat.com/jobs/companies/CombinatoRx.shtmlCombinatoRx Incorporatedhttp://www.ipohome.com/marketwatch/iponews2.asp?article=4843CombinatoRx prices at low end of revised range 11/9/2005 CombinatoRx, which is developing medicines built from synergistic combinations of approved drugs, priced its IPO of 6 million shares at $7 on Wednesday morning.http://www.ipohome.com/marketwatch/iponews2.asp?article=4843CombinatoRx Incorporatedhttp://www.researchandmarkets.com/reports/605392/angiotech_pharmaceuticals_inc_product.pdfThis report is an insightful source for data, analysis and strategic insights into a Angiotech Pharmaceuticals, Inc.’s pipeline and investigational products.http://www.researchandmarkets.com/reports/605392/angiotech_pharmaceuticals_inc_product.pdfCombinatoRx Incorporatedhttp://www.neucoll.com/news/press-releases/?id=592Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced a license and research collaboration agreement with CombinatoRx, Incorporated focused on the selection and development of novel combination pharmaceutical compounds for Angiotech's local interventional therapy applications.http://www.neucoll.com/news/press-releases/?id=592CombinatoRx Incorporatedhttp://www.smartbrief.com/news/fdli/industryBW-detail.jsp?id=79DD7CBC-1DC5-43A3-914A-8C725C23FF1DCRx102 is planned to move forward into Phase 2b clinical studies in both rheumatoid arthritis and osteoarthritis indications and CRx170 is planned to begin Phase 2 clinical development for chronic pain.http://www.smartbrief.com/news/fdli/industryBW-detail.jsp?id=79DD7CBC-1DC5-43A3-914A-8C725C23FF1DCombinatoRx Incorporatedhttp://www.micromedex.com/pressroom/news_feeds/?story_ID=37010&category=4Get the news that matters to you. Create your own customized news service that delivers the latest information directly to you. Plus you can view the most current press releases from Micromedex.http://www.micromedex.com/pressroom/news_feeds/?story_ID=37010&category=4CombinatoRx Incorporatedhttp://www.xconomy.com/boston/2007/06/28/combinatorx-pulls-the-plug-on-arthritis-drug/With today’s announcement, CombinatoRx has reached something of a milestone. The company (which was founded in 2000 by Alexis Borisy, who is incidentally an Xconomist) now has Phase 2 data for all seven drugs in the first wave of candidates in its pipeline.http://www.xconomy.com/boston/2007/06/28/combinatorx-pulls-the-plug-on-arthritis-drug/CombinatoRx Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=21191BIOWIRE2K BOSTON--(BUSINESS WIRE)--Jan. 30, 2006--CombinatoRx, Incorporated (NASDAQ: CRXX) today announced positive preliminary results of its randomized, blinded, placebo-controlled phase 2 clinical trial of CRx-102 in patients with osteoarthritis (OA) of the hand.http://www.pharmacychoice.com/News/article.cfm?Article_ID=21191CombinatoRx Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=28037This trial was designed to determine how immunomodulating agents such as CRx-102 would affect various systemic inflammatory markers in individuals with periodontitis. In the primary endpoint of reduction in C-reactive protein (CRP) at day 42, CRx-102 demonstrated a statistically significant 0.http://www.pharmacychoice.com/News/article.cfm?Article_ID=28037CombinatoRx Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=280502006 MAY 22 - (NewsRx.com) -- CombinatoRx (Singapore) Pte. Ltd., a subsidiary of CombinatoRx, Incorporated (CRXX), has received approval for a grant from the Economic Development Board of Singapore (EDB) Biomedical Sciences Group to support infectious disease drug research and development.http://www.pharmacychoice.com/News/article.cfm?Article_ID=28050CombinatoRx Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=1589CombinatoRx Inc has been awarded a cooperative research grant of up to $4.4 M by The National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health, US Department of Health and Human Services.http://www.pharmacychoice.com/News/article.cfm?Article_ID=1589CombinatoRx Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=50393CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 27, 2007--CombinatoRx, Incorporated (Nasdaq: CRXX) today announced that it will report financial results for the fourth quarter and year ending December 31, 2006 on Tuesday, March 6, 2007 at 7:30 a.m. ET.http://www.pharmacychoice.com/News/article.cfm?Article_ID=50393CombinatoRx Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=9045/PRNewswire/ -- CombinatoRx, Incorporated, a privately held biopharmaceutical company, and HenKan Pharmaceutical Company today announced the signing of a territorial license agreement for CRx-026, a novel dual action anti-cancer agent in clinical development for solid tumors.http://www.pharmacychoice.com/News/article.cfm?Article_ID=9045CombinatoRx Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=14008CombinatoRx to receive $42 million on closing: $27 Million Upfront plus $15 Million Equity Investment To Discover and Develop Drug-Device Combinations and Local Interventional Medicines CombinatoRx, Incorporated and Angiotech Pharmaceuticals, Inc.http://www.pharmacychoice.com/News/article.cfm?Article_ID=14008CombinatoRx Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=52068Report 1: CombinatoRx, Incorporated (CRXX) announced the promotion of Daniel Grau to the newly created position of chief operating officer and the retirement of Dr. Jan Lessem as chief medical officer, effective January 31, 2007. "It is my pleasure to promote Dan to COO.http://www.pharmacychoice.com/News/article.cfm?Article_ID=52068CombinatoRx Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=58734Co-Chairs: Steven Abramson, MD, Professor, Medicine and Pathology, Hospital for Joint Diseases, New York, NY and Josef Smolen, MD, Professor, Rheumatology, Medical University of Vienna, Vienna, Austria. -- Poster #THU0051, Thursday, June 14, 2007, 11:45-1:30pmhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=58734CombinatoRx Incorporated